from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0130/htdZ

LFCtreatmentdescriptionclass of inhibitor

0.376

Amikacinug/mL Amikacintranslation

1.058

Cap5-10ug/mL Capreomycintranslation

2.386

Rox10-50 ug/mL Roxithromycintranslation

-0.745

SM2-5 ug/mL Streptomycintranslation

1.353

Tet5-10 ug/mL Tetracyclinetranslation

0.100

Rif0.2-5ug/mL Rifampicintranscription

-0.237

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.763

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.085

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.790

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.855

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.601

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.279

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.411

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.222

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.827

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.910

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.383

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.558

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.163

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.469

KCN5-20 ug/mL Potassium cyaniderespiration

-0.633

NaN30.2-2 mM Sodium aziderespiration

-0.462

Nigericin50 uM Nigericinrespiration

-0.150

TRC10-150 ug/mL Triclosanrespiration

-1.364

TRZ10-25 ug/mL Thioridazinerespiration

-0.442

Valinomycin0.5-10 uM Valinomycinrespiration

0.325

ZnSO42 mM ZnSO4respiration

-0.834

menadione6-10 ug/mL Menadionerespiration

-0.774

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.032

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.272

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.257

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.810

NRP_1Non-replicating persistence stage 1dosRassociated

0.051

Amp0.2mg/mL AmpicillincellWall

0.381

Cephalexin20-100 ug/mL CephalexincellWall

0.522

Cerulenin0.32-5 ug/mL CerulenincellWall

0.252

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.288

EMB10-20 ug/mL EthambutolcellWall

0.391

Eta12-40 ug/mL EthionamidecellWall

0.235

INH0.2-0.4 ug/mL IsoniazidcellWall

0.191

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.059

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.202

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.042

BZA0.12 mg/mL BenzamidearomaticAmides

1.254

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.362

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.666

H2O24 mM hydrogen peroxideDNAdamaging

0.231

Levo10 ug/mL LevofloxacinDNAdamaging

0.421

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.150

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.760

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.365

UVUV-irradiationDNAdamaging

-1.025

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.044

Antimycin12.5-50 ug/mL Antimycin A?

0.183

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.352

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.349

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.012

PA8240.2-2 ug/mL PA-824?

-0.536

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.178

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.205

Verapamil50 uM Verapamil?

0.397

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.148

methoxatin10-20 ug/mL Methoxatin?